Colossal Biosciences

Google Cloud Launches AI-Powered Multiomics Suite, Taps Dallas-Based Colossal and Form Bio To Help Accelerate Life Science Research

by | May 19, 2023
Google Cloud has unveiled its AI-powered Multiomics Suite, which aims to accelerate the discovery and interpretation of genomic data, helping companies design precision treatments. As part of the rollout, Google Cloud noted that Dallas-based Colossal Biosciences has adopted the Multiomics Suite, and that Colossal spinout Form Bio has been selected to help other organizations adopt it. See what the new suite can do—and how it could help life get scienced.
MORE
SMU Is Bringing Its ‘Innovative Biotech Research’ to Pegasus Park
by | Oct 24, 2022
The Biotech+ Hub at Pegasus Park in Dallas has been attracting more and more life science startups and university teams. Now a whole herd of Mustangs are about to stampede there. The SMU Institute for Computational Biosciences at Pegasus Park will have space at the 23-acre development. SMU researchers from a variety of disciplines will be focusing on bio-scientific discoveries, leveraging advanced computational algorithms and technologies.

"We're excited to give SMU faculty this new opportunity to pursue world-changing research for good and to do so in close proximity to a broad range of academic, medical, corporate, and non-profit collaborators," says SMU Provost Elizabeth Loboa. "We're excited to give SMU faculty this new opportunity to pursue world-changing research for good and to do so in close proximity to a broad range of academic, medical, corporate, and non-profit collaborators," says SMU Provost Elizabeth Loboa.
MORE
acquired
Follow the Money: Medical Device Firm Orthofix Merges to Form Nearly $700M Revenue Business, Stealthy Men’s Health Startup Looks to Raise $2M, Dallas SPAC Targets $200M IPO, and More
by | Oct 17, 2022
In this week’s North Texas deal flow, you’ll also find news about Mavenir’s $155M raise, Pinnacle Realty Advisors raising $5M for ‘brokerage-as-a-service’ platform, Exela Technologies taking its European business unit public, American Airlines’ hydrogen fuel distribution investment, and more.
MORE

The Last Word: Colossal’s Ben Lamm on Seeing His Startup Fuel a ‘Jeopardy’ Answer

by | Oct 3, 2022
In August, Colossal Biosciences announced it is working to "de-extinct" the Tasmanian tiger with the help of an Australian university and “marsupial biobanking.” It didn't take long for the TV show "Jeopardy" to notice—and work it into an answer.
MORE
See Inside: BioLabs Coworking Lab Opens at Pegasus Park for North Texas Life Science Startups
Dallas' status as a growing biotech center got a lift with the official opening of BioLabs, a new coworking space at the Biotech+ Hub at Pegasus Park. The 37,000-square-foot facility offers shared wet labs and office space for up to 35 life science startups.

BioLabs' goal: to serve as the epicenter for life science innovation in North Texas, and to empower biotech trailblazers pursing their next breakthrough.
MORE
Mammoth Project: Dallas’ Colossal Raises $60M to Advance Genetic Engineering and ‘De-Extinction’ Technologies
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid. With a total raise of $75 million to date, the startup aims to have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE